Mark Nelson

Mark L. Nelson, Ph.D. has a vast experience in pharmaceutical research and business development. Mark L. is currently working at Piramal Pharma Solutions and has previously held positions at Altoris, Inc., Neumedics, Inc., CP Lab Chemicals, Frontier Scientific and its subsidiaries, Paratek Pharmaceuticals, Rivier University, and Tufts University School of Medicine. Mark has a strong background in chemistry, biochemistry, and medicinal chemistry, and has made significant contributions to the field through their work on tetracycline derivatives and ocular inflammation treatments.